AI assistant
ALKİM ALKALİ KİMYA A.Ş. — Proxy Solicitation & Information Statement 2026
Apr 9, 2026
5887_rns_2026-04-09_5052cfe0-76ee-4b47-b054-e17e2f465714.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
PROXY
ALKIM ALKALI KIMYA ANONIM ŞİRKETİ
I hereby appoint ..., introduced below in a detailed manner, as my proxy authorized to represent me, cast vote, submit proposals and sign necessary documents in line with the opinions I have specified below during the Ordinary General Meeting of Alkim Alkali Kimya A.Ş. to be held on 09 April 2026, at 14.00 at The Marmara Hotel, Taksim Square, Istanbul.
Proxy’s (*)
Name & Surname/ Corporate Name:
Turkish ID No. / Tax ID No., Trade Registry Office and Trade Registration Number and, MERSES Number:
(*) For the foreign national proxies, the equivalent of the said information must be submitted.
A) SCOPE OF THE POWER OF REPRESENTATION
For the following sections 1 and 2, one of the options (a), (b) or (c) must be selected to identify the scope of the power of representation.
- Concerning the Agenda Items of the General Meeting;
a) The Proxy is authorized to cast vote in line with their own opinion.
b) The Proxy is authorized to cast vote in line with the recommendations of the company's management.
c) The Proxy is authorized to cast vote in line with the instructions specified on the following table.
Instructions:
In case a shareholder selects the option (c), the instructions on an agenda item are given by means of choosing one of the options concerning that agenda item of the general meeting (acceptation or refusal) and if the refusal option is selected, then the instructions are given by means of specifying the dissenting options requested to be indicated on the minutes of the general meeting.
| Agenda Items (*) | Accept | Refuse | Dissenting Option |
|---|---|---|---|
| 1. Opening and formation of the Chairman of the Meeting | |||
| 2. Reading and deliberation on the Annual Report of the Board of Directors for the accountancy period of 2025 | |||
| 3. Reading the Report of the Independent Auditing Firm for the accountancy period of 2025 | |||
| 4. Reading, deliberation on and approval of the Financial Statements for the accountancy period of 2025 | |||
| 5. Reading and discussion of the TSRS-compliant Sustainability Report for the 2024 fiscal year. | |||
| 6. Approval of the selection of the Independent Audit Institution for the 2026 Accounting Period | |||
| 7. Approval of the selection of the Sustainability Report Assurance Audit Firm for the 2026 fiscal year. | |||
| 8. Discharge of the members of the Board of Directors from the company's activities, transactions and accounts for the 2025 accounting period | |||
| 9. Informing the shareholders about the "Remuneration Policy" of the members of the Board of Directors and senior executives in accordance with the regulations of the Capital Markets Board | |||
| 10. Determination of monthly gross salaries and attendance fees of Board Members | |||
| 11. Discussion and decision on the proposal of the Board of Directors regarding the distribution of profits for the accounting period of 2024 | |||
| 12. Authorizing the Board of Directors to sell all or a portion of the shares of the affiliate (subsidiary) of our company traded at Borsa Istanbul A.Ş.'de (BIST) | |||
| 13. Authorizing the Board of Directors to sell the building of the General Office of our company located in İnönü Cad. No:13 Taksim Beyoğlu Istanbul |
| 14. Informing the General Assembly Regarding the Donation and Contributions made in 2025 and resolving the limitations to be made in 2026. | |||
|---|---|---|---|
| 15. Informing the shareholders of the guarantees, liens, mortgages and securities granted by our company in favor of 3rd parties in 2025 | |||
| 16. Granting permission to the shareholders controlling the management, the members of the Board of Directors, the executives with administrative responsibilities and, their spouses and relatives by blood and by marriage up to second degree as per the articles 395 and 396 of the Turkish Commercial Code and, the regulations of the Capital Market Board and, informing the shareholders of the transactions carried out in this scope within the accounting period of 2025 | |||
| 17. Providing information to shareholders about our Company's Related Party Transactions prepared of Article 9 of the Corporate Governance Communique numbered II-17.1 published by the Corporate Markets Board | |||
| 18. Wishes and requests |
(*) All the items on the agenda of the General Meeting are individually listed. In case there is separate resolution draft of the minority, then this will be separately indicated to allow for voting by proxy.
- Special instruction concerning other issues that may arise during the General Meeting, in particular, the use of the minority rights:
a) The Proxy is authorized to cast vote in line with their own opinion.
b) The Proxy is not authorized in these issues.
c) The Proxy is authorized to cast vote in line with the following special instructions.
SPECIAL INSTRUCTIONS; the special instructions if any given by the principal to the proxy are specified here.
B) The shareholder specifies the shares the shareholder wants the proxy to represent by means of selecting one of the following options.
- I hereby approve that the proxy will represent my shares, the details of which are provided below.
a) Order and serial: *
b) Number/Group: **
c) Quantity-Nominal value:
ç) Voting right share or not:
d) Bearer or Registered shares: *
e) Ratio to the total shares/voting rights the principle holds:
This information is not requested for the shares monitored on records.
*For the shares monitored on records, the respective group will be specified instead of the number.
- I hereby approve that the proxy will represent all of my shares that appear on the list of shareholders eligible to attend the general meeting as prepared by the CRA one day before the general meeting.
SHAREHOLDER'S NAME & SURNAME or CORPORATE NAME (*)
Turkish ID No. /Tax ID No., Trade Registry Office and Trade Registration Number and, MERSİS Number:
Address:
(*) For the foreign national shareholders, the equivalent of the said information must be submitted.